Lyra therapeutics to host virtual chronic rhinosinusitis kol event on august 31

Watertown, mass., aug. 17, 2021 (globe newswire) -- lyra therapeutics, inc. (nasdaq: lyra), a clinical-stage therapeutics company leveraging its proprietary xtreo™ platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ent) passages and other diseased tissues will host chronic rhinosinusitis (crs) key opinion leader event on tuesday, august 31, 2021 from 3:00 p.m. - 4:30 p.m. et.
LYRA Ratings Summary
LYRA Quant Ranking